#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects


HIV progression is characterized by immune activation and microbial translocation. One factor that may be contributing to HIV progression could be a dysbiotic microbiome. We therefore hypothesized that the GI mucosal microbiome is altered in HIV patients and this alteration correlates with immune activation in HIV. 121 specimens were collected from 21 HIV positive and 22 control human subjects during colonoscopy. The composition of the lower gastrointestinal tract mucosal and luminal bacterial microbiome was characterized using 16S rDNA pyrosequencing and was correlated to clinical parameters as well as immune activation and circulating bacterial products in HIV patients on ART. The composition of the HIV microbiome was significantly different than that of controls; it was less diverse in the right colon and terminal ileum, and was characterized by loss of bacterial taxa that are typically considered commensals. In HIV samples, there was a gain of some pathogenic bacterial taxa. This is the first report characterizing the terminal ileal and colonic mucosal microbiome in HIV patients with next generation sequencing. Limitations include use of HIV-infected subjects on HAART therapy.


Vyšlo v časopise: A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects. PLoS Pathog 10(2): e32767. doi:10.1371/journal.ppat.1003829
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003829

Souhrn

HIV progression is characterized by immune activation and microbial translocation. One factor that may be contributing to HIV progression could be a dysbiotic microbiome. We therefore hypothesized that the GI mucosal microbiome is altered in HIV patients and this alteration correlates with immune activation in HIV. 121 specimens were collected from 21 HIV positive and 22 control human subjects during colonoscopy. The composition of the lower gastrointestinal tract mucosal and luminal bacterial microbiome was characterized using 16S rDNA pyrosequencing and was correlated to clinical parameters as well as immune activation and circulating bacterial products in HIV patients on ART. The composition of the HIV microbiome was significantly different than that of controls; it was less diverse in the right colon and terminal ileum, and was characterized by loss of bacterial taxa that are typically considered commensals. In HIV samples, there was a gain of some pathogenic bacterial taxa. This is the first report characterizing the terminal ileal and colonic mucosal microbiome in HIV patients with next generation sequencing. Limitations include use of HIV-infected subjects on HAART therapy.


Zdroje

1. SandlerNG, WandH, RoqueA, LawM, NasonMC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203: 780–790.

2. OstrowskiSR, PiironenT, Hoyer-HansenG, GerstoftJ, PedersenBK, et al. (2005) High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients. J Acquir Immune Defic Syndr 39: 23–31.

3. KlattNR, FunderburgNT, BrenchleyJM (2013) Microbial translocation, immune activation, and HIV disease. Trends Microbiol 21: 6–13.

4. BrenchleyJM, SchackerTW, RuffLE, PriceDA, TaylorJH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749–759.

5. BrenchleyJM, PriceDA, SchackerTW, AsherTE, SilvestriG, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365–1371.

6. GoriA, TincatiC, RizzardiniG, TortiC, QuirinoT, et al. (2008) Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol 46: 757–758.

7. MerliniE, BaiF, BellistriGM, TincatiC, d'Arminio MonforteA, et al. (2011) Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy. PLoS One 6: e18580.

8. GoriA, RizzardiniG, Van't LandB, AmorKB, van SchaikJ, et al. (2011) Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial. Mucosal Immunol 4: 554–563.

9. HandleySA, ThackrayLB, ZhaoG, PrestiR, MillerAD, et al. (2012) Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell 151: 253–266.

10. McKennaP, HoffmannC, MinkahN, AyePP, LacknerA, et al. (2008) The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog 4: e20.

11. BrayJR, CurtisCT (1957) An ordination of upland forest communities of southern Wisconsin. Ecological Monographs 27: 325–349.

12. LozuponeC, KnightR (2005) UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71: 8228–8235.

13. VaziriND, WongJ, PahlM, PicenoYM, YuanJ, et al. (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83: 308–315.

14. CheungMK, LamWY, FungWY, LawPT, AuCH, et al. (2013) Sputum Microbiota in Tuberculosis as Revealed by 16S rRNA Pyrosequencing. PLoS One 8: e54574.

15. ColomboAP, BochesSK, CottonSL, GoodsonJM, KentR, et al. (2009) Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J Periodontol 80: 1421–1432.

16. SatoT, YamakiK, IshidaN, HashimotoK, TakeuchiY, et al. (2012) Cultivable anaerobic microbiota of infected root canals. Int J Dent 2012: 609689.

17. RolphHJ, LennonA, RiggioMP, SaundersWP, MacKenzieD, et al. (2001) Molecular identification of microorganisms from endodontic infections. J Clin Microbiol 39: 3282–3289.

18. RammaertB, BorandL, GoyetS, TeV, HemS, et al. (2010) Ralstonia pickettii community-acquired pneumonia in Cambodia. Int J Tuberc Lung Dis 14: 1653–1654.

19. PanW, ZhaoZ, DongM (2011) Lobar pneumonia caused by Ralstonia pickettii in a sixty-five-year-old Han Chinese man: a case report. J Med Case Rep 5: 377.

20. DaviesJC, RubinBK (2007) Emerging and unusual gram-negative infections in cystic fibrosis. Semin Respir Crit Care Med 28: 312–321.

21. BarbutF, KosmannMJ, LalandeV, NeymeD, CoppoP, et al. (2006) Outbreak of Ralstonia pickettii pseudobacteremia among patients with hematological malignancies. Infect Control Hosp Epidemiol 27: 642–644.

22. XuJ, MooreJE, MillarBC, AlexanderHD, McClurgR, et al. (2004) Improved laboratory diagnosis of bacterial and fungal infections in patients with hematological malignancies using PCR and ribosomal RNA sequence analysis. Leuk Lymphoma 45: 1637–1641.

23. RyanMP, PembrokeJT, AdleyCC (2006) Ralstonia pickettii: a persistent gram-negative nosocomial infectious organism. J Hosp Infect 62: 278–284.

24. EnaJ, Simon-AylonA, PasquauF (2009) Intestinal spirochetosis as a cause of chronic diarrhoea in patients with HIV infection: case report and review of the literature. Int J STD AIDS 20: 803–805.

25. WattsDH (2012) Mother to child transmission of HIV–another complication of bacterial vaginosis? J Acquir Immune Defic Syndr 60: 221–224.

26. FrankDN, ManigartO, LeroyV, MedaN, ValeaD, et al. (2012) Altered vaginal microbiota are associated with perinatal mother-to-child transmission of HIV in African women from Burkina Faso. J Acquir Immune Defic Syndr 60: 299–306.

27. SaxenaD, LiY, YangL, PeiZ, PolesM, et al. (2012) Human microbiome and HIV/AIDS. Curr HIV/AIDS Rep 9: 44–51.

28. SpearGT, GilbertD, LandayAL, ZariffardR, FrenchAL, et al. (2011) Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species. Appl Environ Microbiol 77: 378–381.

29. HummelenR, FernandesAD, MacklaimJM, DicksonRJ, ChangaluchaJ, et al. (2010) Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 5: e12078.

30. SpearGT, SikaroodiM, ZariffardMR, LandayAL, FrenchAL, et al. (2008) Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis 198: 1131–1140.

31. Structure, function and diversity of the healthy human microbiome. Nature 486: 207–214.

32. SanapareddyN, LeggeRM, JovovB, McCoyA, BurcalL, et al. (2012) Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J 6: 1858–1868.

33. HansenR, RussellRK, ReiffC, LouisP, McIntoshF, et al. (2012) Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 107: 1913–1922.

34. ManichanhC, Rigottier-GoisL, BonnaudE, GlouxK, PelletierE, et al. (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205–211.

35. EllisCL, MaZM, MannSK, LiCS, WuJ, et al. (2011) Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr 57: 363–370.

36. Vujkovic-CvijinI, DunhamRM, IwaiS, MaherMC, AlbrightRG, et al. (2013) Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism. Sci Transl Med 5: 193ra191.

37. SankaranS, GeorgeMD, ReayE, GuadalupeM, FlammJ, et al. (2008) Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82: 538–545.

38. EppleHJ, SchneiderT, TroegerH, KunkelD, AllersK, et al. (2009) Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 58: 220–227.

39. SmithAJ, SchackerTW, ReillyCS, HaaseAT (2010) A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection. J Acquir Immune Defic Syndr 55: 306–315.

40. CostiniukCT, AngelJB (2012) Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity? Mucosal Immunol 5: 596–604.

41. AhmedS, MacfarlaneGT, FiteA, McBainAJ, GilbertP, et al. (2007) Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl Environ Microbiol 73: 7435–7442.

42. NavaGM, StappenbeckTS (2011) Diversity of the autochthonous colonic microbiota. Gut Microbes 2: 99–104.

43. WilsonNL, MoneyhamLD, AlexandrovAW (2013) A Systematic Review of Probiotics as a Potential Intervention to Restore Gut Health in HIV Infection. J Assoc Nurses AIDS Care 24: 98–111.

44. SchunterM, ChuH, HayesTL, McConnellD, CrawfordSS, et al. (2012) Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complement Altern Med 12: 84.

45. Gonzalez-HernandezLA, Jave-SuarezLF, Fafutis-MorrisM, Montes-SalcedoKE, Valle-GutierrezLG, et al. (2012) Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. Nutr J 11: 90.

46. SmithDM, SnowDE, ReesE, ZischkauAM, HansonJD, et al. (2010) Evaluation of the bacterial diversity of pressure ulcers using bTEFAP pyrosequencing. BMC Med Genomics 3: 41.

47. WolcottRD, GontcharovaV, SunY, DowdSE (2009) Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol 9: 226.

48. SenR, IshakHD, EstradaD, DowdSE, HongE, et al. (2009) Generalized antifungal activity and 454-screening of Pseudonocardia and Amycolatopsis bacteria in nests of fungus-growing ants. Proc Natl Acad Sci U S A 106: 17805–17810.

49. IshakHD, PlowesR, SenR, KellnerK, MeyerE, et al. (2011) Bacterial diversity in Solenopsis invicta and Solenopsis geminata ant colonies characterized by 16S amplicon 454 pyrosequencing. Microb Ecol 61: 821–831.

50. CaporasoJG, KuczynskiJ, StombaughJ, BittingerK, BushmanFD, et al. (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7: 335–336.

51. EdgarRC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26: 2460–2461.

52. EdgarRC, HaasBJ, ClementeJC, QuinceC, KnightR (2011) UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27: 2194–2200.

53. HaasBJ, GeversD, EarlAM, FeldgardenM, WardDV, et al. (2011) Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 21: 494–504.

54. CaporasoJG, BittingerK, BushmanFD, DeSantisTZ, AndersenGL, et al. (2010) PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26: 266–267.

55. McDonaldD, PriceMN, GoodrichJ, NawrockiEP, DeSantisTZ, et al. (2012) An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 6: 610–618.

56. WernerJJ, KorenO, HugenholtzP, DeSantisTZ, WaltersWA, et al. (2012) Impact of training sets on classification of high-throughput bacterial 16s rRNA gene surveys. ISME J 6: 94–103.

57. WangQ, GarrityGM, TiedjeJM, ColeJR (2007) Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73: 5261–5267.

58. PriceMN, DehalPS, ArkinAP (2010) FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One 5: e9490.

59. DufreneM, LegendreP (1997) Species assemblages and indicator species: the need for a flexible asymmetrical approach. Ecological Monographs 67: 345–366.

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2014 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#